Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-MS10 in Acute and Chronic Gastritis
NCT01578811Phase 2Completed
- Sponsor
- SK Chemicals
- Start
- Aug 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cochinchina momordica seed extract in erosive gastritis (3 arms), sponsored by SK Chemicals. Primary endpoint: Improvement rates of erosive gastritis according to the Sydney classification at 2 weeks. Started Aug 2011; status: completed.
02
Drugs
cochinchina momordica seed extract
03
Conditions
erosive gastritis
Beyond the preview
Go deeper on NCT01578811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578811.